The UNC13A gene helps nerve cells release chemical messengers so signals can pass smoothly through the brain and spinal cord. If it does not work well, these messages may not be sent properly, which can affect movement, learning, or seizure control in rare inherited conditions. Some common variants in the UNC13A gene are also linked to a higher risk or faster progression of amyotrophic lateral sclerosis, also called ALS, and some related forms of frontotemporal dementia. These variants influence risk rather than acting as a diagnosis on their own.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions they can use to make molecules or regulate processes in the body. Some genes carry the code for proteins, the parts of cells that do much of the work. Others mainly direct when certain processes happen, where they occur, and how strongly they operate. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this subject in greater depth, you can find more in the LearnHub.
Overview
UNC13AGene function
What if the gene works
The UNC13A gene helps nerve cells prepare and release chemical signals at synapses. This supports smooth communication in the brain and spinal cord, which helps with movement, thinking, and other everyday nervous system functions.
Risk
What if the gene does not work
Variants in the UNC13A gene can affect nerve cell signaling. Common variants are linked to higher risk and faster progression in amyotrophic lateral sclerosis and some frontotemporal dementia, while rarer, more severe variants may cause earlier and broader neurologic problems.
Treatment
What does that mean for your treatment
No UNC13A-specific treatment or drug choice is currently established for pathogenic or loss-of-function variants in the UNC13A gene. In ALS research, the UNC13A gene is being studied as a prognostic marker and a possible treatment target because some variants may shape how TDP-43 related damage affects the gene.
Gene function
What if the gene works
If you carry the UNC13A gene, it helps nerve cells pass messages from one cell to the next. Its protein works at the sending end of these connections, where it gets tiny packets of chemical messengers ready to go. Understanding how the UNC13A gene helps nerve cells communicate makes its role in movement, thinking, and sensation easier to picture.
UNC13A helps prepare tiny messenger packets in nerve endings so they can be released at the right moment. This preparation step lets the packets move into a ready position before the signal is sent.
When an electrical signal reaches a nerve ending, this gene helps those packets join with the cell surface and release their contents. That allows chemical messengers to cross to the next cell and keep information moving.
UNC13A also helps control the timing and strength of message release during repeated nerve activity. This fine tuning supports smooth communication in brain circuits used for movement, attention, learning, and other everyday tasks.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the UNC13A gene can change how much full-length protein a cell makes or alter parts needed for folding and partner binding. Some common changes make cells more prone to editing the UNC13A message incorrectly, so an extra segment is inserted and less working protein is produced; this is an example of how UNC13A gene variants affect protein function. Milder variants may only partly lower protein activity, while more severe variants can leave little or no functional protein.
How variants are linked to conditions
Common variants in the UNC13A gene are most strongly linked to amyotrophic lateral sclerosis (ALS). Research on variants in the UNC13A gene and ALS also suggests a link with frontotemporal dementia and with differences in survival after ALS begins. These findings describe risk and disease course at a population level, so a common UNC13A variant does not by itself diagnose or predict these conditions.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal feature of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition suggests a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific day-to-day factors that increase or reduce health risk related to the UNC13A gene itself. Some changes in UNC13A are linked with a higher chance of conditions such as ALS in research studies, but personal risk still depends on many other genetic and non-genetic factors.
Inheritance of UNC13A variants
There is not yet a broadly confirmed disease inheritance pattern for the UNC13A gene in the way seen with classic single gene conditions. Most discussion of UNC13A inheritance involves common gene changes that may influence the chance of conditions such as ALS rather than directly causing a condition on their own. In practical terms, how UNC13A is inherited follows the usual pattern for genes on nonsex chromosomes: you receive one copy from each parent. The UNC13A gene is located on chromosome 19, an autosome, so inheritance is generally similar in males and females.
What does my UNC13A result mean for my family?
There isn’t yet a broadly confirmed inheritance pattern tied to a specific condition for UNC13A in the way there is for some single-gene conditions. Some UNC13A findings are better understood as affecting risk rather than clearly predicting that relatives will develop a disease. If you have a specific UNC13A result, its meaning for family members depends on the exact change that was found.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the UNC13A gene, labs analyze DNA from a blood or saliva sample as part of a panel, exome, or genome test. This is how genetic testing for UNC13A variants works: a lab reads the gene's DNA code and reports whether a variant is found, including markers that may influence risk rather than confirm a diagnosis.
When should I consider getting a genetic test?
UNC13A testing is not usually done on its own. It may be considered as part of a broader genetics evaluation for unexplained severe brain or nerve symptoms, or in some families affected by ALS, a disease that causes progressive muscle weakness.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies based on the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in the genes involved in handling drugs can change how quickly a medicine is processed, how strongly it works, or how likely side effects are. This helps explain why the same treatment works well for one person, works less well for another, or feels too strong even at a usual dose.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. It focuses on connections between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. Understanding this can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the UNC13A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, drug response, or new symptoms are best discussed with your doctor.
History
UNC13A entered human genetics through work on nerve signaling genes, after earlier research on the related unc-13 gene in roundworms helped guide naming and discovery. In recent decades, awareness of this gene’s role has grown. A major shift came when large genetic studies linked common variants near the UNC13A gene to amyotrophic lateral sclerosis, often called ALS, and later to frontotemporal dementia in some groups. From these first observations, research expanded steadily. Studies published in the 2010s and early 2020s clarified that UNC13A became especially important in understanding how inherited risk can shape disease course in people with changes involving TDP-43, a protein linked to ALS and related conditions. Today, UNC13A is a well known research focus in neurogenetics.